Updated on 2025/11/20

写真a

 
TOGASHI Keita
 
Title
Assistant Professor
 

Papers

  • Nationwide multicenter prospective study on the usefulness, safety, and acceptability of colon capsule endoscopy in Japan., Gastrointestinal endoscopy, 101(5) 1051-1063.e7, 2025.05

    Hotta N, Ohmiya N, Hiraga H, Nakaji K, Osawa S, Omori T, Mitsufuji S, Hosoe N, Nouda S, Kobayashi T, Nakamura M, Oka S, Nonogaki K, Baba Y, Mukai R, Matsumoto H, Ikebuchi Y, Shimada M, Togashi K, Kats...

    Single Author

  • NOVEL MDM4 INHIBITOR CEP-1347-BASED THERAPY FOR P53 WILD-TYPE MALIGNANT MENINGIOMA, NEURO-ONCOLOGY, 26 , 2024.11

    Mitobe, Y; Suzuki, S; Nakagawa-Saito, Y; Togashi, K; Sugai, A; Sonoda, Y; Kitanaka, C; Okada, M

    Single Author

  • CEP-1347 Boosts Chk2-Mediated p53 Activation by Ionizing Radiation to Inhibit the Growth of Malignant Brain Tumor Cells, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 25(17) , 2024.09

    Mitobe, Y; Suzuki, S; Nakamura, K; Nakagawa-Saito, Y; Takenouchi, S; Togashi, K; Sugai, A; Sonoda, Y; Kitanaka, C; Okada, M

    Single Author

  • Novel Molecularly Targeted Therapy for Retinoblastoma Through Activation of MDM4-p53 Pathway, INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 65(7) , 2024.06

    Togashi, K; Yutaka, K; Yamashita, H; Sugimoto, M

    Single Author

  • The MDM2-p53 Axis Represents a Therapeutic Vulnerability Unique to Glioma Stem Cells, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 25(7) , 2024.04

    Nakagawa-Saito, Y; Mitobe, Y; Togashi, K; Suzuki, S; Sugai, A; Takenouchi, S; Nakamura, K; Sonoda, Y; Kitanaka, C; Okada, M

    Single Author

  • CEP-1347 Dually Targets MDM4 and PKC to Activate p53 and Inhibit the Growth of Uveal Melanoma Cells, CANCERS, 16(1) , 2024.01

    Togashi, K; Suzuki, S; Mitobe, Y; Nakagawa-Saito, Y; Sugai, A; Takenouchi, S; Sugimoto, M; Kitanaka, C; Okada, M

    Single Author

  • Antagonizing MDM2 Overexpression Induced by MDM4 Inhibitor CEP-1347 Effectively Reactivates Wild-Type p53 in Malignant Brain Tumor Cells, CANCERS, 15(17) , 2023.09

    Mitobe, Y; Suzuki, S; Nakagawa-Saito, Y; Togashi, K; Sugai, A; Sonoda, Y; Kitanaka, C; Okada, M

    Single Author

  • Domatinostat Targets the FOXM1-Survivin Axis to Reduce the Viability of Ovarian Cancer Cells Alone and in Combination with Chemotherapeutic Agents, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 24(13) , 2023.07

    Nakagawa-Saito, Y; Mitobe, Y; Suzuki, S; Togashi, K; Sugai, A; Kitanaka, C; Okada, M

    Single Author

  • The Novel MDM4 Inhibitor CEP-1347 Activates the p53 Pathway and Blocks Malignant Meningioma Growth In Vitro and In Vivo, BIOMEDICINES, 11(7) , 2023.07

    Mitobe, Y; Suzuki, S; Nakagawa-Saito, Y; Togashi, K; Sugai, A; Sonoda, Y; Kitanaka, C; Okada, M

    Single Author

  • In vitro and in vivo anti-tumor effects of brexpiprazole, a newly-developed serotonin-dopamine activity modulator with an improved safety profile., Oncotarget, 10(37) 3547-3558, 2019.05

    Suzuki S, Yamamoto M, Togashi K, Sanomachi T, Sugai A, Seino S, Yoshioka T, Kitanaka C, Okada M

    Single Author

  • Involvement of GLUT1-mediated glucose transport and metabolism in gefitinib resistance of non-small-cell lung cancer cells., Oncotarget, 9(66) 32667-32679, 2018.08

    Suzuki S, Okada M, Takeda H, Kuramoto K, Sanomachi T, Togashi K, Seino S, Yamamoto M, Yoshioka T, Kitanaka C

    Single Author

display all >>